Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,348.04 85.48 0.53%
S&P 500 1,849.82 6.84 0.37%
NASDAQ 4,052.65 18.49 0.46%
Ticker Volume Price Price Delta
STOXX 50 3,123.37 31.85 1.03%
FTSE 100 6,569.08 27.47 0.42%
DAX 9,264.69 90.98 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Dr. Joe McCord, LifeVantage Corporation's First Chief Science Officer, Retires From Company



Dr. Joe McCord, LifeVantage Corporation's First Chief Science Officer, Retires
From Company

SALT LAKE CITY, June 25, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, announced today that Dr. Joe McCord, LifeVantage's first
Chief Science Officer, a member of the initial management team, past board
member, LifeVantage Scientific Advisory Board member and pioneering researcher
in anti-aging science has retired from the Company.

"Dr. McCord's co-discovery in 1969 of superoxide dismutase (SOD), an enzyme
that eliminates free radicals, laid the foundation for a critical area of
anti-aging research and provided the scientific foundation for LifeVantage's
cornerstone products, Protandim®, the Nrf2 Synergizer® patented dietary
supplement, TrueScience® Anti-Aging Cream and LifeVantage® Canine Health,"
said LifeVantage President and Chief Executive Officer Douglas C. Robinson.

"Since then," Robinson noted, "Dr. McCord has been named lead or co-author on
a remarkable body of work, encompassing 212 published scientific articles on
related matters, including the roles of SOD and/or Nrf2 in oxidative stress;
heart, liver, lung, brain, muscle and other organ health; the mechanism and
effects of Protandim; implications for cancer treatment, and more.

"In view of his long association with LifeVantage, dating from 2004, and his
groundbreaking and continuing scientific exploration of oxidative stress, Nrf2
and Protandim, I know I am joined by the entire LifeVantage family, including
more than 60,000 independent distributors worldwide and over 140,000 other
customers, in celebrating Dr. McCord's service and wishing him the very best
in the future," Robinson said.

Early LifeVantage investor and past board member H. Leigh Severance said of
Dr. McCord, "Joe is one of those rare geniuses who not only discovers new
scientific facts, but who encourages others to build on their groundbreaking
research, expanding the breadth of knowledge and applications. Even more, Joe
has the skills to help those of us in the financial community understand the
value of his work, and to attract talented business executives capable of
transforming science into extraordinarily successful commercial products. We
are truly indebted to Joe for his great accomplishments."

During his career, Dr. McCord was a Professor of Medicine, Biochemistry,
Biophysics, and Molecular Genetics, and Microbiology/Immunology at the
University of Colorado at Denver. Dr. McCord also served as the head of the
Division of Biochemistry and Molecular Biology at the Webb-Waring Institute,
as a faculty member at Duke University's Department of Medicine and as a
Professor and Chairman of the Department of Biochemistry at the University of
South Alabama College of Medicine. Early in his career, Dr. McCord's doctoral
dissertation described the discovery of SOD, a discovery that earned him the
Elliott Cresson Medal, the highest award given by The Franklin Institute.

Dr. McCord will continue providing limited consulting services to the Company
over the next nine months to promote further research on Protandim.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker
of Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience®
Anti-Aging Cream and LifeVantage^® Canine Health, is a science based
nutraceutical company. LifeVantage is dedicated to visionary science that
looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, UT.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         -or-
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement